GlassScriptPhysician profile
Clinton L Dille
NPI 1306947569
$1,885.85
in general payments reported to CMS, 2019-2025
24 companies · $409 in 2025
The $409 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $212 · 2021: $228 · 2022: $358 · 2023: $98.05 · 2024: $267 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $773.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $544.45 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Medtronic, INC. | $363.80 | 2023-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Accurian |
| Spinefrontier, INC. | $183.90 | 2025 | Facetfuse, Nanofuse, Sijfuse |
| Stimwave Technologies Incorporated | $109.54 | 2019-2022 | |
| Stryker Corporation | $99.93 | 2019 | |
| Biodelivery Sciences International, INC. | $80.47 | 2019-2021 | |
| Abbvie INC. | $66.61 | 2022-2025 | |
| Pfizer INC. | $58.93 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.72 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $46.05 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $37.33 | 2023 | Quviviq |
| Medtronic USA, INC. | $32.48 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $30.38 | 2019 | |
| Saluda Medical Americas, INC. | $27.65 | 2024 | Evoke |
| Redhill Biopharma INC. | $25.68 | 2020-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $19.94 | 2024 | Generator |
| Vertos Medical, INC. | $15.57 | 2023 | Mild Device Kit |
| Merck Sharp & Dohme LLC | $15.23 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $15.16 | 2024 | |
| Lilly USA, LLC | $13.32 | 2021 | |
| Allergan, INC. | $12.49 | 2019 | |
| Bioventus LLC | $11.59 | 2020 | |
| Mdd US Operations, LLC | $10.82 | 2019 | |
| Curonix LLC | $10.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Dille listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.